Clinical Trials
3 trialsNCT04803929 2021-03-23
Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)
Carbiogene Therapeutics Co. Ltd.
Phase EARLY_PHASE1 Unknown
NCT01031368 2019-03-01
Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia
Nohla Therapeutics, Inc.
Phase 1 Completed
NCT00363974 2009-12-01
Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML
Aegera Therapeutics
Phase 1/2 Completed